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Gas-phase hydrogen/deuterium exchange of D2O with [M 1 H]
1 ions of angiotensin II,
angiotensin I, [Sar1]-angiotensin II, bradykinin, des-Arg1-bradykinin, des-Arg9-bradykinin,
luteinizing hormone releasing hormone (LH-RH), and substance P has been examined by
Fourier transform ion cyclotron resonance mass spectrometry at 9.4 tesla. Because the FTICR
dynamic range increases quadratically with magnetic field, parent ions from a mixture of
several peptides may be confined simultaneously for long periods at high pressure (e.g., 1 h at
1 3 1025 torr) without quadrupolar axialization (and its attendant ion heating), for faster data
acquisition and better controlled comparisons between different peptides. A high magnetic
field also facilitates stored waveform inverse Fourier transform (SWIFT) isolation of monoiso-
topic [M 1 H]1 parent ions, so that deuterium incorporation patterns may be determined
directly without the need for isotopic distribution deconvolution. Finally, a higher magnetic
field provides for a greatly extending trapping period, for measurement of much slower rates.
Angiotensin I, angiotensin II, and [Sar1]-angiotensin II are found to undergo a rapid exchange.
Angiotensin II and [Sar1]-angiotensin II exhibit multiple deuterium uptake distributions,
corresponding to multiple gas-phase conformations. In contrast, substance P exchanges slowly
and LH-RH displays no observable exchange. Comparison of the relative H/D exchange rates
for bradykinin and its des-Arg-derivatives supports the hypothesis that bradykinin adopts a
folded gas-phase conformation that unfolds upon removal of either terminal arginine residue.
(J Am Soc Mass Spectrom 1998, 9, 1012–1019) © 1998 American Society for Mass Spectrometry
Hydrogen/deuterium exchange is a powerfulprobe for the investigation of peptide confor-mation, based on the accessibility of various
potentially exchangeable protons [1]. To date, most H/D
exchange studies performed on peptides have been con-
ducted in solution, in which an aqueous peptide is sud-
denly switched to a D2O buffer, and the degree of subse-
quent deuterium incorporation determined by nuclear
magnetic resonance (NMR) or mass spectrometry [2–14].
In a critical comparison, the H/D amide exchange rate
constants determined from mass spectrometry for a
particular protein (FK506-binding protein) were shown
to match and extend those from proton NMR [15],
thereby validating the application of mass spectrometry
to proteins inaccessible by NMR (due to too-low solu-
bility, too-high molecular weight, aggregation, etc.).
Recently, there has been increasing interest in the
gas-phase structure and conformations of peptides and
proteins [16-25], because gas-phase peptide and protein
ions typically contain no water molecules, thereby pro-
viding for more direct comparison to theoretically derived
structures. Also, comparison of solution and gas-phase
structures should help to clarify the role(s) of water in
peptide and protein structures. Mass spectrometry is
especially well suited for characterization of gas-phase
H/D exchange of ionic peptides, because deuterium in-
corporation can be monitored directly from the time
profile for mass increase of the peptide or protein ion
following introduction of liquid or gaseous D2O. In par-
ticular, ion trapping techniques, such as Fourier transform
ion cyclotron resonance (FTICR) and quadrupole ion
traps, provide for determination of the kinetics of
gas-phase exchange experiments because ions may be
trapped for extended periods, allowing for observation
of the relatively slow H/D exchange processes [26].
Because the rate constants for gas-phase H/D ex-
change of singly charged amino acids or peptides with
D2O are small (,10
211 cm3 molecules s21), measure-
ment of such rate constants may require a long trapping
period (minutes to hours) and/or high neutral reagent
gas pressure. However, collisionally driven magnetron
Address reprint requests to Professor Alan G. Marshall, National High
Magnetic Field Laboratory, Florida State University, 1800 East Paul Dirac
Drive, Tallahassee, FL 32310. E-mail: marshall@magnet.fsu.edu
*Member of the Department of Chemistry, Florida State University, Talla-
hassee, FL.
© 1998 American Society for Mass Spectrometry. Published by Elsevier Science Inc. Received March 25, 1998
1044-0305/98/$19.00 Revised May 28, 1998
PII S1044-0305(98)00080-4 Accepted May 29, 1998
radius expansion limits the maximum trapping period,
particularly at a magnetic field of B # 7 tesla, because
the maximum trapping period varies as B2 [27]. It is
possible to overcome magnetron expansion by applying
azimuthal quadrupolar excitation to convert magnetron
motion to cyclotron motion (which is, in turn, rapidly
damped by ion-neutral collisions) [28–33]. Unfortu-
nately, during the quadrupolar “axialization” process,
magnetron-to-cyclotron conversion speeds up ions and
increases their translational temperature in a compli-
cated way, thereby affecting any ion-molecule reaction
kinetics measurement.
Here we show that gas-phase H/D exchange (as an
example of gas-phase ion-molecule reaction kinetics in
general) benefits in several important ways by perform-
ing FTICR experiments at a higher magnetic field (in
this case, 9.4 tesla). First, the maximum number of ions
that can be confined in an ICR (Penning) ion trap (and
hence the FTICR Mass Spectrometry maximum signal-
to-noise ratio and dynamic range) increases as B2 [27].
The higher dynamic range greatly reduces the time
required for kinetics measurements. For example, the
time required to determine H/D exchange kinetics for a
single decapeptide can consume an entire day. Wood et
al. have previously demonstrated simultaneous gas-
phase H/D exchange on different charge states of
cytochrome-c ions by use of stored waveform inverse
Fourier transform (SWIFT) excitation to isolate either
the all-odd or the all-even parent ion charge states [34].
In that spirit, we present here a similar approach for
performing simultaneous H/D exchange on mixtures of
chemically different peptides by use of a high-field (9.4
tesla) FTICR mass spectrometer. Moreover, experi-
ments can be much better controlled by simultaneous
detection of several different species at once, rather than
having to compare experiments performed at different
times on individual species. Second, because the maxi-
mum ion trapping period increases as B2 [27], it be-
comes possible to measure much slower reaction rates.
Third, because the cyclotron frequency separation be-
tween ions of adjacent mass-to-charge (m/z) values
increases directly with B, operation at higher magnetic
field makes it easier to eject ions of nearby mass-to-charge
ratio values, so as to isolate a particular isotopic species for
unambiguous spectral analysis (see below). In this
paper, we demonstrate all of the above advantages of
higher magnetic field, and also provide a general pro-
tocol for optimal measurement of gas-phase H/D ex-
change rates for peptides, extending over several orders
of magnitude difference in rate constants, including
examples of multiple mechanisms (e.g., multiple con-
formations) for ions of a single elemental composition.
Experimental
Instrumental
All mass spectra were acquired with a homebuilt 9.4
tesla electrospray ionization (ESI) FTICR instrument
configured for external accumulation [35, 36]. Samples
were infused from a tapered 50 mm inner diameter (i.d.)
fused silica microelectrospray ionization [37] needle at
500 nL min21 at a concentration of 10 mmol/L. Typical
ESI conditions were 1.8 kV needle voltage and 3.5 A
heated capillary current. The experimental event se-
quence is shown in Figure 1. Ions were accumulated in
a linear octupole ion trap for 1–5 s and then transmitted
to a three-section open cylindrical 4-in.-diameter Pen-
ning trap (trapping voltage, 4 V) through a second
octupole ion guide. The most abundant monoisotopic
[M 1 H]1 ions were isolated by a combination of fre-
quency sweep [38, 39] and SWIFT dipolar excitations
[40–42] (Figure 2) to eject radially ions of other mass-
to-charge ratios. The isolated parent ions were then
allowed to react with gaseous D2O pulsed into the
vacuum system with a General Valve (Fairfield, NJ)
series 9 three-way pulsed valve in combination with a
Varian Vacuum Products (Lexington, MA) Model
9515906 leak valve operating as previously described by
Freiser and co-workers [43]. The partial pressure of D2O
during the pulse rose to 1 3 1025 torr within 2 s [as
indicated by an ion gauge (Model 274, Granville Phil-
lips, Boulder, CO)] and remained stable throughout the
subsequent course of H/D exchange. Ions were allowed
to react with D2O for varying time periods up to a
maximum of 1 h. The exchange reagent pulse was
followed by a 6-min pumpdown during which the
pressure fell rapidly (;10 s) to 2 3 1027 torr and
achieved a final pressure of 8 3 1028 torr. A relaxation
interval of 60 s was inserted after the ion isolation
pulses to reduce fragmentation because of collisions
between translationally hot ions and high-pressure neu-
tral D2O molecules. Immediately following hydrogen/
deuterium exchange, the ions were subjected to fre-
quency sweep excitation (48–280 kHz at 300 Hz/ms)
and direct-mode broadband detection (512 Kword data
points and 300-kHz Nyquist bandwidth). A typical
chamber base pressure was 1–5 3 1029 torr. All exper-
iments were controlled by an Odyssey data station
(Finnigan, Madison, WI). All experimental transients
were subjected to baseline correction, Hanning apodiza-
Figure 1. Electrospray ionization FTICR mass spectrometry ex-
perimental event sequence for slow gas-phase H/D exchange
reactions.
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tion, and one zero fill prior to fast Fourier transform
(FFT) followed by magnitude calculation.
Error, Reproducibility, and Trapping Period
To establish the reproducibility of the H/D exchange
experiments, we allowed angiotensin II to undergo
H/D exchange with D2O individually and in two
separate mixtures on three different days. The repro-
ducibility for the three separate H/D exchange experi-
ments of angiotensin II was , 610% (Figure 3). An
important benefit of performing the exchange experi-
ments simultaneously is that the pressure of the neutral
exchange reagent is identical for all species, thereby
eliminating any error associated with pressure repro-
ducibility. However, because the ion gauge is located
more than a meter from the ICR cell, differences in
pumping speeds at the trap and ion gauge will produce
a large difference in the apparent versus true pressure
reading [44]. Without prior calibration of the ion gauge,
the absolute assignment of rate constants was not
possible.
A second source of systematic error originates from
the decrease in signal-to-noise ratio due to gradual loss
of ions by magnetron radius expansion [45–47] over the
course of the experiment. Because LH-RH exhibits
negligible H/D exchange for up to an hour at 1 3 1025
torr, it serves as a convenient control to monitor the
decrease in signal-to-noise ratio because of ion loss
(Figure 4). Over the course of 1 h, the signal-to-noise
ratio for LH-RH decreased by a factor of ,10. Because
precision in determination of FTICR mass spectral peak
height or area is proportional to the signal-to-noise ratio
[48], the relative error in determination of deuterium
uptake for other peptides will necessarily increase with
time during the experiment. Figure 4 also clearly illus-
trates two advantages that derive from operation at 9.4
tesla. First, the high magnetic field, B, allows for a
significantly longer trapping period (proportional to B2
[27]) because of slower radial magnetron expansion
resulting in radial ejection. A longer trapping period
therefore extends proportionately the lower limit of
measurable H/D exchange rate constants. Second (see
Figure 4), higher single-scan signal-to-noise ratios are
achievable because of the high field (number of trapped
ions scales as B2 [27]) and large (4-in-diameter) cylin-
drical ICR cell (number of trapped ions scales as the
square of the cell diameter) of our instrument. As
higher fields become available, even further improve-
ments in the quality of H/D exchange rate measure-
ments can be expected.
Sample Preparation
Angiotensin I, angiotensin II, [Sar1]-angiotensin II, bra-
dykinin, des-Arg1-bradykinin, des-Arg9-bradykinin, lu-
teinizing hormone releasing hormone (LH-RH), and
substance P were purchased from Sigma Chemical
Company (St. Louis, MO). Deuterium oxide (D2O,
%D 5 99.9%) was purchased from the Aldrich Chemi-
cal Company (Milwaukee, WI). All reagents were used
without further purification. Angiotensin II and LH-RH
Figure 2. ESI FTICR mass spectra of des-Arg1-bradykinin and
bradykinin before (top) and after (bottom) SWIFT isolation of the
[M 1 H]1 ions.
Figure 3. Deuterium incorporation vs. time profiles for gas-
phase H/D exchange of angiotensin II with D2O (1 3 10
25 torr).
Reproducibility is indicated by the error bars, which represent two
standard deviations for three measurements. The solid line indi-
cates a theoretical fit to yield rate constants for the 17 exchange-
able hydrogens [15]. The number of potentially exchangeable
hydrogens is shown next to each backbone amide, terminal, or
side chain hydrogen in the peptide sequence.
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were dissolved in 50:50 MeOH:H2O to an initial con-
centration of 1 mmol/L each, and diluted to a final
concentration of 10 mmol/L in 50:50 MeOH:H2O with
0.25% acetic acid. The peptide mixtures were prepared
similarly except that the final peptide concentrations
were optimized to yield approximately equal relative
ion abundance for each isolated [M 1 H]1 parent ion.
The final concentrations for each mixture were: (1) 20
mmol/L bradykinin and 10 mmol/L des-Arg1-bradyki-
nin; (2) 25 mmol/L angiotensin II, 100 mmol/L brady-
kinin, 40 mmol/L des-Arg9, bradykinin, and 25 mmol/L
LH-RH; (3) 20 mmol/L angiotensin II, 10 mmol/L an-
giotensin I, 30 mmol/L [Sar1]-angiotensin II, and 10
mmol/L substance P.
Results and Discussion
In each of the following experiments, we first isolate the
monoisotopic (i.e., all carbons are 12C; all nitrogens are
15N; all oxygens are 16O) peptide protonated ions,
[M 1 H]1. Thus, there is no ambiguity arising from the
presence of naturally abundant heavy isotopes (and
need for deconvolution [49]) or impurities or adducts in
determining the distribution of incorporated deuterium
atoms. The relative number of ions with 0, 1, 2, 3, . . .
deteriums is simply obtained directly from the relative
abundances of singly charged ions of mass, M 1 1,
M 1 2, M 1 3, . . . .
H/D Exchange of Angiotensin II and LH-RH
Angiotensin II and LH-RH were independently sub-
jected to gas-phase H/D exchange with D2O at an ion
gauge reading of 1 3 1025 torr. These peptides offer a
good contrast, because angiotensin II exchanged 13 of
its 17 exchangeable hydrogens over a period
L-Asp-Arg-Val-Tyr-lle-His-Pro-Phe
(Amino acid sequence for angiotensin II)
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg
(Amino acid sequence for luteinizing hormone
(Amino acid sequence for luteinizing
hormone releasing hormone)
during which LH-RH did not undergo any observable
exchange (Figure 5). An interesting aspect of angioten-
sin II’s reactivity is the presence of at least two gas-
phase conformations manifested by the two resolved
deuterium uptake distributions developed during H/D
exchange (Figure 6). The observation of two conforma-
tions would have been much less apparent without
prior isolation of the monoisotopic [M 1 H]1 ions.
Some obvious questions are: (1) which gas-phase con-
formations are present?; (2) do those conformations
interconvert?; and (3) are those conformations directly
analogous to those found in solution? At present, no
different comparisons with solution phase [50, 51] and
gas-phase conformations have been made for angioten-
sin II. We are continuing to investigate H/D exchange
of angiotensins I, II, III, and their derivatives to address
those questions.
For peptides with a large number of exchangeable
hydrogens, the assignment of rate constants can be
quite tedious [26]. Recently, Zhang et al. demonstrated
a maximum entropy method (MEM) to determine the
rate constants for H/D exchange [49]. The MEM fit
(Figure 7) to the time profile for gas-phase deuterium
uptake by angiotensin II (Figure 3) reveals three clearly
resolved distributions of H/D exchange rate constants.
Figure 4. Single-scan signal-to-noise ratio vs. time for LH-RH in
the presence of D2O (1 3 10
25 torr). This experiment provides a
control for establishing the rate of ion nonreactive loss from the
ion trap (see text).
Figure 5. ESI FTICR mass spectra of angiotensin II (top) and
LH-RH (bottom) after 1 h of H/D exchange with D2O (1 3 10
25
torr).
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Simultaneous Exchange of Bradykinin and des-
Arg1-bradykinin
We next consider simultaneous H/D exchange for a
mixture of two closely related peptides, bradykinin and
its des-Arg1 derivative (removal of arginine group in
position 1).
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
(Amino acids sequence for bradykinin)
As for angiotensin II and LH-RH, the H/D exchange
profiles for the two peptides are strikingly different.
Bradykinin undergoes relatively slow exchange
whereas the removal of an arginine from the amino
terminus increases the relative exchange rate dramati-
cally (Figure 8). A similar increase in H/D exchange
rate relative to bradykinin was also observed for its
des-Arg9 derivative (see next section), in which an
arginine residue is removed from the carboxyl-termi-
nus. The simplest explanation is that bradykinin adopts
a compact gas-phase conformation in which its ex-
changeable hydrogens are inaccessible to D2O. Schnier
et al. [52] and T. Wyttenbach and M. T. Bowers (per-
sonal communications of unpublished results) have
proposed that bradykinin adopts a zwitterionic form
that may lead to a folded salt bridgelike conformation.
Removal of either arginine residue breaks the salt
bridge and allows the conformation to unfold, thereby
accounting for the increased relative exchange rate of
either of the two des-Arg-bradykinins relative to bra-
dykinin itself. The large difference in exchange rates
between the des-Arg1 and des-Arg9 derivatives (Figures
8, and 9) may arise from local conformational effects in
which the N-terminal amine is protonated. The appli-
cation of force-field calculations (in progress) to exam-
ine the gas-phase conformations should prove useful in
rationalizing the H/D exchange rates. However, careful
consideration of the chosen force-field parameters is
required. Additional experiments to investigate puta-
tive salt-bridged species are currently under way on the
[M 1 Na]1, [M 1 2H]21, and [M 1 H, Na]21 bradyki-
nin ions, along with the [M 1 H]1 and [M 1 Na]1 ions
of its methyl ester.
Simultaneous Exchange of Angiotensin II,
Bradykinin, des-Arg9-bradykinin, and LH-RH
Deuterium uptake versus time profiles from simulta-
neous gas-phase H/D exchange of a mixture of four
Figure 6. ESI FTICR mass spectra of angiotensin II (top) and
[Sar1]-angiotensin II (bottom) after 300 and 60 s, respectively, of
H/D exchange with D2O (1 3 10
25 torr).
Figure 7. Rate constant distribution for angiotensin II reacting
with D2O (1 3 10
25 torr) based on maximum entropy method fit
to the reaction progress curves [15].
Figure 8. Deuterium incorporation vs. time profiles for gas-
phase simultaneous H/D exchange of bradykinin and des-Arg1-
bradykinin with D2O (1 3 10
25 torr).
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peptides angiotensin II, bradykinin, des-Arg9-bradyki-
nin, and LH-RH, are shown in Figure 10. Note that the
data for angiotensin II, bradykinin, and LH-RH are in
excellent agreement with prior experiments, further
confirming the reproducibility of such measurements.
As noted in the previous section, des-Arg9-bradykinin
exchanges faster than bradykinin and slower than des-
Arg1-bradykinin. A nice benefit from the four-peptide
mixture is the increase in sample throughput gained by
performing the experiments simultaneously. The H/D
exchange experiment on the four peptide mixture re-
quired 9 h, compared to a combined 24 h required for
four separate experiments. Alternatively, for a given
total experimental data collection period, signal averag-
ing could be used to improve the signal-to-noise ratio
compared to one-peptide-at-a-time analysis.
Simultaneous Exchange of Angiotensin II,
Angiotensin I, [Sar1]-angiotensin II, and
Substance P
The final set of simultaneous exchange experiments
were performed on the four peptide mixture of angio-
tensin II, angiotensin I, [Sar1]-angiotensin II, and sub-
stance P. Their deuterium uptake versus time profiles
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
(Amino acid sequence for angiotensin I)
Arg-Pro-Iys-Pro-Gln-Gin-Phe-Phe-Gly-Leu-Met-NH2
(Amino acid sequence for substance P)
are presented in Figure 11. Again, the reaction progress
curve for angiotensin II was in good agreement with
those from previous experiments. Angiotensin I and
[Sar1]-angiotensin II exchange rapidly with D2O. [Sar
1]-
angiotensin II also displays multiple gas-phase confor-
mations (Figure 6). Substance P, on the other hand,
exchanges very slowly. Of all the peptides we exam-
ined, angiotensin I exhibited the fastest relative ex-
change rate. The only structural difference between
angiotensin I and II is the presence of a C-terminal
His-Leu amino acid sequence in the former peptide. We
are investigating angiotensin I, II, III, and their deriva-
tives to elucidate the role of the His-Leu residues on
gas-phase conformations of angiotensin I and II.
Figure 9. ESI FTICR mass spectra of des-Arg9-bradykinin (top)
and des-Arg1-bradykinin (bottom) after 1 h of simultaneous H/D
exchange with D2O (1 3 10
25 torr).
Figure 10. Deuterium incorporation vs. time profiles for gas-
phase simultaneous H/D exchange of angiotensin II, bradykinin,
des-Arg9-bradykinin, and LH-RH with D2O (1 3 10
25 torr).
Figure 11. Deuterium incorporation vs. time profiles for gas-
phase simultaneous H/D exchange of angiotensin II, angiotensin
I, [Sar1]-angiotensin II, and substance P with D2O (1 3 10
25 torr).
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Conclusion and Future Directions
In this article, we have demonstrated several advan-
tages of high magnetic field FTICR mass spectrometry
for rapid and well-controlled determination of gas-
phase H/D exchange kinetics for peptide mixtures:
improved isolation of monoisotopic species leading to
simpler data analysis; longer ion trapping period lead-
ing to extended range of accessible rate constants;
higher dynamic range for simultaneous analysis of
several species; enhanced reproducibility; and decrease
in required data acquisition period and/or an improve-
ment in the quality of experimental data. The present
data reveal large differences in accessibility of D2O to
gas-phase peptide ions of comparable molecular
weight, showing that gas-phase H/D exchange is an
extraordinarily sensitive probe of peptide structure. The
present results prompt many questions that will be
addressed in future experiments on these and other
peptides and proteins: e.g., amino acid interactions in
both bradykinin and angiotensin related peptides; ef-
fects of solution phase conditions (e.g., pH, tempera-
ture, solvent composition) on gas-phase exchange rates
of species electrosprayed from those solutions; exten-
sion of the method to characterize noncovalent interac-
tions of peptides; and extension to larger multiply
charged ions.
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